Delivery Order SPE2DR25D2102-SPE2DR26FB2QG
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,274.10 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, awarded on January 23, 2026, is structured as a firm fixed-price delivery order with an ultimate completion date of February 13, 2026. This is a competitively awarded contract with no set-aside designation, and performance will take place at the awardee's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a...
- The Defense Logistics Agency awarded a delivery order valued at $3,370.11 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents, with an ultimate completion date of February 20, 2026. This firm fixed-price, non-set-aside contract was awarded on January 29, 2026, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a $101,928 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract was competitively awarded without set-aside designation and is scheduled for completion by February 10, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a leading pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $3,370.11 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents, with an ultimate completion date of February 20, 2026. This competitively awarded, firm fixed-price contract without set-aside designation is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $2,105.92 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents, with a completion date of October 8, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and supplies comprehensive pharmaceutical products and...
- The Defense Logistics Agency awarded a delivery order valued at $63,705.00 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract was competitively awarded without set-aside restrictions and carries a firm fixed-price structure, with performance scheduled for completion by February 12, 2026. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and pharmaceutical...
- The Defense Logistics Agency awarded Amerisourcebergen Drug Corp a delivery order valued at $3,822.30 on January 27, 2026, for the supply of Varivax vaccine with diluents. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of February 18, 2026, to be performed at the contractor's facility in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $183,470.40 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. This firm fixed-price, non-set-aside contract was awarded on January 20, 2026, with an ultimate completion date of February 10, 2026. The vaccine will be delivered to the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving federal...
- The Defense Logistics Agency awarded a $12,741 firm fixed-price delivery order to AmerisourceBergen Drug Corp (parent company Cencora, Inc.) on January 22, 2026, for the supply of Varivax vaccine with diluents. This non-set-aside contract is scheduled for completion by February 12, 2026, with performance at the awardee's facility in Conshohocken, Pennsylvania. The delivery order was issued competitively under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $2,246.76 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, which carries a firm fixed price structure, was competitively awarded without a set-aside designation and is scheduled for completion by February 20, 2026. The place of performance is listed as Conshohocken, Pennsylvania, which serves as the company's corporate headquarters. This delivery order was issued under AmerisourceBergen's...
- SPE2DR25D2102Indefinite Delivery Contract
- SPE2DR25D2102-SPE2DR26FB2QGDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,123.37 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents, with an ultimate completion date of February 26, 2026. This is a firm fixed-price, non-set-aside contract with performance in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor that supplies critical medical products to federal government agencies, particularly supporting military and veteran healthcare systems. This delivery order is issued under Cencora, Inc.'s larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical (SPE2DX), valued at up to $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains to support military healthcare programs worldwide. The contract supports customers including the Defense Health Agency, U.S. Coast Guard, and other federal government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 2/3/26 |